Bleeding News and Research

RSS

Clinical trial shows safety, effectiveness of pre-prepared cells to treat drug-resistant viral infections

Patients who receive a hematopoietic stem cell transplant are at risk of developing potentially lethal viral infections. Some of the infections can be treated with available drugs, but they are not always effective and side effects can be significant.

8 Aug 2017

Researchers reveal promising results of new noninvasive method of ICP monitoring

Researchers from Klinikum Stuttgart and the University of Erlangen, Germany, report preliminary findings that show a noninvasive method of monitoring intracranial pressure (ICP) that could rival the gold standards of invasive intraventricular and intraparenchymal monitoring.

8 Aug 2017

New profiling procedure reveals role of immunoresolvents in blood coagulation

Stopping a wound from bleeding is essential for human health. Blood coagulation - in which blood goes from liquid to gel and forms a clot - can prevent excessive bleeding and infection. But exactly what molecular events transpire when blood coagulates has remained somewhat mysterious.

4 Aug 2017

Protein that protects fetus during pregnancy could help treat atopic dermatitis

A protein which protects the fetus during pregnancy, HLA-G1, shows high potential for treating atopic dermatitis and other related diseases.

4 Aug 2017

Studies show how endoscopic procedures can improve outcomes and care

Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy, features a study reporting that a simpler procedure for collecting biopsy specimens during various procedures can improve patient care, and a study showing how a relatively new procedure, POEM, has been adapted to help an additional set of patients with gastroparesis, a troubling stomach problem.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Researchers develop new scoring method to predict bleeding risk after stroke

A new scoring method may help predict who is at high risk of serious bleeding after a stroke, according to a study published in the August 2, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Aug 2017

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Common anti-allergy medicines could prove to be an effective treatment for potentially fatal blood clots in the legs, according to new research by the University of Birmingham.

2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

WPI researchers receive NIH grant to develop heart muscle patch using biopolymer microthreads

A research team at Worcester Polytechnic Institute has been awarded a $452,000 National Institutes of Health grant to bioengineer a patch to help cardiac muscle beat more strongly and efficiently after a heart attack.

31 Jul 2017

Culture of silence around vaginal bleeding poses threat to women's health

The culture of silence around vaginal bleeding at all stages of life endangers women's health and is compounded by limited access to clean water, sanitation, and factual information in low and middle-income countries, according to a study conducted at Columbia University's Mailman School of Public Health. The findings are published in the online journal BMJ Global Health.

31 Jul 2017

Study finds no significant benefits of cooling down cardiac arrest patients for 48 hours

A five per cent difference in favor of the 48 hours. This is the result of a study from Aarhus University that has spent several years examining the possible benefits of cooling down patients suffering cardiac arrest to 33°C for 48 hours, instead of the 24-hours that is standard practice in most places.

26 Jul 2017

SLUCare obstetricians examine novel device to treat postpartum hemorrhage

SLUCare obstetricians are leading a clinical trial at SSM Health St. Mary's Hospital that investigates a possible approach to treat postpartum hemorrhage, the leading cause of perinatal maternal death around the world.

24 Jul 2017

Diagnosing prostate cancer through a £225 urine test

This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.

24 Jul 2017

Sexual health clinics should ask patients about domestic violence and abuse

Training clinicians to proactively ask patients about domestic violence is feasible for sexual health clinics to implement and could increase referrals to specialist services, according to a study by Queen Mary University of London and the University of Bristol involving over 4,300 women.

20 Jul 2017

Bleeding News and Research

Clinical trial shows safety, effectiveness of pre-prepared cells to treat drug-resistant viral infections

Researchers reveal promising results of new noninvasive method of ICP monitoring

New profiling procedure reveals role of immunoresolvents in blood coagulation

Protein that protects fetus during pregnancy could help treat atopic dermatitis

Studies show how endoscopic procedures can improve outcomes and care

FDA approves new treatment for all HCV genotypes 1-6

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Researchers develop new scoring method to predict bleeding risk after stroke

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

WPI researchers receive NIH grant to develop heart muscle patch using biopolymer microthreads

Culture of silence around vaginal bleeding poses threat to women's health

Study finds no significant benefits of cooling down cardiac arrest patients for 48 hours

SLUCare obstetricians examine novel device to treat postpartum hemorrhage

Diagnosing prostate cancer through a £225 urine test

Sexual health clinics should ask patients about domestic violence and abuse

IBS scientists create first nanoparticle-based tissue adhesive to seal bleeding and guide surgery

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

In Massachusetts, proposed Medicaid cuts put kids’ health care at risk

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News